Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Organ Dysfunction Scores | 1 | 2021 | 13 | 0.800 |
Why?
|
| Asthma | 5 | 2021 | 345 | 0.690 |
Why?
|
| Hip Fractures | 1 | 2019 | 26 | 0.650 |
Why?
|
| Osteoporosis | 1 | 2019 | 88 | 0.620 |
Why?
|
| Electronic Health Records | 1 | 2021 | 374 | 0.620 |
Why?
|
| Veterans | 1 | 2019 | 904 | 0.390 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 2 | 2021 | 20 | 0.380 |
Why?
|
| Retrospective Studies | 12 | 2022 | 7268 | 0.340 |
Why?
|
| Anti-Asthmatic Agents | 2 | 2019 | 56 | 0.310 |
Why?
|
| Telemedicine | 2 | 2021 | 699 | 0.220 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2022 | 15 | 0.210 |
Why?
|
| Health Information Systems | 1 | 2022 | 18 | 0.210 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2022 | 38 | 0.210 |
Why?
|
| Logistic Models | 3 | 2021 | 1419 | 0.190 |
Why?
|
| Monte Carlo Method | 1 | 2021 | 124 | 0.190 |
Why?
|
| Child | 9 | 2022 | 6401 | 0.190 |
Why?
|
| Infliximab | 1 | 2020 | 16 | 0.190 |
Why?
|
| Medicaid | 2 | 2021 | 301 | 0.190 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 1 | 2021 | 28 | 0.190 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2020 | 52 | 0.180 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 232 | 0.170 |
Why?
|
| Limb Salvage | 1 | 2019 | 39 | 0.170 |
Why?
|
| Osteosarcoma | 1 | 2019 | 35 | 0.170 |
Why?
|
| Intensive Care Units | 1 | 2021 | 344 | 0.170 |
Why?
|
| Mobile Applications | 1 | 2021 | 138 | 0.170 |
Why?
|
| Salvage Therapy | 1 | 2019 | 82 | 0.170 |
Why?
|
| Comparative Effectiveness Research | 1 | 2019 | 36 | 0.170 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 100 | 0.160 |
Why?
|
| Diuretics | 1 | 2019 | 96 | 0.160 |
Why?
|
| Health Expenditures | 1 | 2021 | 168 | 0.160 |
Why?
|
| United States | 6 | 2021 | 7338 | 0.160 |
Why?
|
| Ambulatory Care | 1 | 2021 | 339 | 0.160 |
Why?
|
| Rotator Cuff Injuries | 1 | 2019 | 32 | 0.160 |
Why?
|
| Humans | 16 | 2022 | 68549 | 0.150 |
Why?
|
| Echocardiography | 1 | 2021 | 515 | 0.150 |
Why?
|
| Reoperation | 1 | 2019 | 467 | 0.150 |
Why?
|
| Glucocorticoids | 1 | 2019 | 222 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 467 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 929 | 0.140 |
Why?
|
| Child, Preschool | 5 | 2021 | 3187 | 0.130 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 366 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 498 | 0.130 |
Why?
|
| Blood Pressure | 1 | 2020 | 1449 | 0.120 |
Why?
|
| Risk Factors | 2 | 2019 | 5720 | 0.100 |
Why?
|
| Male | 8 | 2021 | 37283 | 0.100 |
Why?
|
| Female | 8 | 2021 | 38021 | 0.100 |
Why?
|
| Aged | 4 | 2020 | 14842 | 0.100 |
Why?
|
| Young Adult | 2 | 2019 | 5710 | 0.100 |
Why?
|
| Infant, Newborn | 3 | 2022 | 2455 | 0.090 |
Why?
|
| School Health Services | 2 | 2021 | 72 | 0.090 |
Why?
|
| Heart Failure | 1 | 2019 | 1179 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 1085 | 0.090 |
Why?
|
| Middle Aged | 4 | 2020 | 21119 | 0.080 |
Why?
|
| Insurance Claim Review | 2 | 2019 | 39 | 0.080 |
Why?
|
| Infant | 3 | 2021 | 2891 | 0.080 |
Why?
|
| Adolescent | 4 | 2021 | 8904 | 0.070 |
Why?
|
| Adult | 3 | 2019 | 21379 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2019 | 621 | 0.070 |
Why?
|
| Hospitalization | 2 | 2021 | 977 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 1054 | 0.060 |
Why?
|
| Prognosis | 2 | 2020 | 2093 | 0.060 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 711 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 3256 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2020 | 7028 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2019 | 2004 | 0.050 |
Why?
|
| Critical Illness | 1 | 2022 | 191 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 2020 | 193 | 0.050 |
Why?
|
| Schools | 1 | 2021 | 156 | 0.040 |
Why?
|
| Cerebral Revascularization | 1 | 2020 | 45 | 0.040 |
Why?
|
| Perception | 1 | 2021 | 189 | 0.040 |
Why?
|
| Goals | 1 | 2020 | 65 | 0.040 |
Why?
|
| Propensity Score | 1 | 2019 | 116 | 0.040 |
Why?
|
| Injections, Intra-Articular | 1 | 2019 | 15 | 0.040 |
Why?
|
| SEER Program | 1 | 2019 | 150 | 0.040 |
Why?
|
| Rotator Cuff | 1 | 2019 | 25 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 50 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 214 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 233 | 0.040 |
Why?
|
| Arthroscopy | 1 | 2019 | 95 | 0.040 |
Why?
|
| Length of Stay | 1 | 2020 | 780 | 0.040 |
Why?
|
| Medicare | 1 | 2019 | 316 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 1055 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 503 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2018 | 346 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1745 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 1425 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2265 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2020 | 665 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2020 | 1615 | 0.030 |
Why?
|
| Hypertension | 1 | 2020 | 1533 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 4843 | 0.020 |
Why?
|
| Stroke | 1 | 2020 | 2162 | 0.020 |
Why?
|